Literature DB >> 1754818

Pathogenic anti-DNA idiotype (16/6 Id) in systemic lupus erythematosus.

Y Shoenfeld1, E Mozes.   

Abstract

Systemic lupus erythematosus (SLE) is regarded as a classical autoimmune disease. Despite this belief, no one has been able to induce the disease in naive animals, neither with DNA nor with anti-DNA antibodies. We report on the induction of SLE in BALB/c mice following immunization with a pathogenic anti-DNA idiotype (16/6 Id) or its anti-Id. We also report on a specific treatment with T suppressor cells specific for the 16/6 Id. The induction of SLE in naive mice with a pathogenic anti-DNA Id suggests an additional mechanism for the diversity of manifestations in this disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1754818     DOI: 10.1007/bf00304494

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  22 in total

1.  The importance of the pathogenic 16/6 idiotype in the induction of SLE in naive mice.

Authors:  M Blank; M Krup; S Mendlovic; H Fricke; E Mozes; N Talal; A R Coates; Y Shoenfeld
Journal:  Scand J Immunol       Date:  1990-01       Impact factor: 3.487

2.  Monoclonal anti-tuberculosis antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis.

Authors:  Y Shoenfeld; Y Vilner; A R Coates; J Rauch; G Lavie; D Shaul; J Pinkhas
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

3.  Human monoclonal anti-DNA antibodies react as lymphocytotoxic antibodies.

Authors:  Y Shoenfeld; R Zamir; H Joshua; G Lavie; J Pinkhas
Journal:  Eur J Immunol       Date:  1985-10       Impact factor: 5.532

4.  Production of autoantibodies by human-human hybridomas.

Authors:  Y Shoenfeld; S C Hsu-Lin; J E Gabriels; L E Silberstein; B C Furie; B Furie; B D Stollar; R S Schwartz
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

5.  Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus.

Authors:  D A Isenberg; Y Shoenfeld; R S Schwartz
Journal:  Arthritis Rheum       Date:  1984-02

6.  Detection of cross reactive anti-DNA antibody idiotypes on tissue-bound immunoglobulins from skin biopsies of lupus patients.

Authors:  D Isenberg; C Dudeney; F Wojnaruska; B S Bhogal; J Rauch; A Schattner; Y Naparstek; D Duggan
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

7.  Use of monoclonal antibodies to identify shared idiotypes on human antibodies to native DNA from patients with systemic lupus erythematosus.

Authors:  G Solomon; J Schiffenbauer; H D Keiser; B Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

8.  Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice.

Authors:  A D Steinberg; J B Roths; E D Murphy; R T Steinberg; E S Raveche
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

9.  Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice.

Authors:  J R Roubinian; N Talal; J S Greenspan; J R Goodman; P K Siiteri
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

10.  Idiotypic cross-reactions of monoclonal human lupus autoantibodies.

Authors:  Y Shoenfeld; D A Isenberg; J Rauch; M P Madaio; B D Stollar; R S Schwartz
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  3 in total

1.  Idiotype usage by polyclonally activated B cells in experimental autoimmunity and infection.

Authors:  M Sutmuller; J J Baelde; M P Madaio; J A Bruijn; E De Heer
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

2.  Pathogenic and Epiphenomenal Anti-DNA Antibodies in SLE.

Authors:  Mirjana Pavlovic; Anna Kats; Michelle Cavallo; Ran Chen; James X Hartmann; Yehuda Shoenfeld
Journal:  Autoimmune Dis       Date:  2010-07-20

3.  In silico Analyses of Skin and Peripheral Blood Transcriptional Data in Cutaneous Lupus Reveals CCR2-A Novel Potential Therapeutic Target.

Authors:  Rama Dey-Rao; Animesh A Sinha
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.